Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRIME-Sepsis Trial: Presepsin and Immature Granulocytes for Multicenter Early Sepsis Detection in the Emergency Department: A Prospective Observational Study

NCT07822412 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.

NCT NCT07822412
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07822412 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRIME-Sepsis Trial: Presepsin and Immature Granulocytes for Multicenter Early Sepsis Detection in the Emergency Department: A Prospective Observational Study
Lead sponsor
Chang Gung Memorial Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
April 30, 2029
Enrollment
699 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, septic shock